Avidity Partners Management LP Orchard Therapeutics PLC Transaction History

Avidity Partners Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.23 $4.45 Million - $8.56 Million	-3,836,798 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.24 - $4.29 $123,200 - $235,950	55,000 Added 1.45%	3,836,798 $8.83 Million
Q2 2021 Aug 16, 2021	SELL	$4.39 - $7.23 $2.35 Million - $3.88 Million	-536,002 Reduced 12.41%	3,781,798 $16.6 Million
Q1 2021 May 17, 2021	BUY	$4.39 - $9.08 $19 Million - $39.2 Million	4,317,800 New	4,317,800 $31.3 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.